The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ALLO-316 in advanced clear cell renal cell carcinoma (ccRCC): Updated results from the phase 1 TRAVERSE study.
 
Samer Srour
Consulting or Advisory Role - Hansa Biopharma; Novartis
Travel, Accommodations, Expenses - Allogene Therapeutics
 
Jad Chahoud
Consulting or Advisory Role - AVEO; DAVA Pharmaceuticals; Eisai; Exelixis; Merck; Pfizer
Research Funding - AB Science (Inst); Allogene Therapeutics (Inst); Exelixis (Inst); Merck (Inst); Pfizer (Inst); Xilio Therapeutics (Inst)
 
Alexandra Drakaki
Employment - ATHOS THERAPEUTICS (I); ATTICA SCIENCES (I); Dyania Health (I)
Leadership - ATHOS THERAPEUTICS (I); ATTICA SCIENCES (I)
Stock and Other Ownership Interests - Alimera Sciences (I); Athos Therapeutics (I); ATTICA SCIENCES; Dyania Health (I); Kyn therapeutics (I); Moderna Therapeutics (I); PROTEAS BIOANALYTICS (I); Urogen pharma (I)
Consulting or Advisory Role - AstraZeneca; AVEO; Bristol-Myers Squibb; Daichi-Sanchyo; DYANIA HEALTH; EMD Serono; EMD Serono; Exelixis; Infinity Pharmaceuticals; Janssen; Loxo/Lilly; Merck; PACT Pharma; RADMETRIX; Roche/Genentech; Seagen
Research Funding - AstraZeneca (Inst); BMS (Inst); Genentech/Roche (Inst); Immunomedics/Gilead (Inst); Infinity Pharmaceuticals (Inst); Jounce Therapeutics (Inst); Kite/Gilead; Merck Sharp & Dohme (Inst); Pfizer (Inst); Seattle Genetics/Astellas (Inst)
Patents, Royalties, Other Intellectual Property - My significant other has several patents with UCLA, Harvard Medical School, Athos Therapeutics, Proteas Bioanalytics and ATTICA Sciences (I)
Travel, Accommodations, Expenses - AstraZeneca; Lilly; Seagen
 
Brendan Curti
Honoraria - Asante Health; St Joseph Hospital
Consulting or Advisory Role - Merck; Werewolf Therapeutics
Research Funding - Ankyra Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst)
Patents, Royalties, Other Intellectual Property - Biomarkers for OX40 response (Inst)
Travel, Accommodations, Expenses - Asante Health; St Joseph Hospital
 
Geoffrey Gibney
Consulting or Advisory Role - Bristol-Myers Squibb; HUYA Bioscience International; Immunocore; Iovance Biotherapeutics; Lyell Immunopharma; Merck; Novartis; Pfizer; Regeneron; Replimune
Speakers' Bureau - Immunocore
Research Funding - Exelixis (Inst)
 
Sumanta Pal
Speakers' Bureau - IntrinsiQ; MJH Life Sciences; Peerview
Travel, Accommodations, Expenses - crispr therapeutics; Exelixis; Ipsen
 
Lily Tang
Employment - Allogene Therapeutics; Nektar
Stock and Other Ownership Interests - Allogene Therapeutics; Gilead Sciences; Nektar
 
Sara Charmsaz
Employment - Allogene Therapeutics; Sonoma Biotherapeutics
Stock and Other Ownership Interests - Sonoma Biotherapeutics
Patents, Royalties, Other Intellectual Property - Sonoma Biotherapeutics
 
Joy Atwell
Employment - Allogene Therapeutics
 
Paul Robbins
Employment - Allogene Therapeutics
Stock and Other Ownership Interests - Allogene Therapeutics
 
Chelsea Williams
Employment - Allogene Therapeutics
Stock and Other Ownership Interests - Allogene Therapeutics
 
Sri Ghatta
Employment - Allogene Therapeutics
Stock and Other Ownership Interests - Allogene Therapeutics
 
Chris Severyn
Employment - Allogene Therapeutics
Stock and Other Ownership Interests - Allogene Therapeutics
 
John Le Gall
Employment - Allogene Therapeutics
Stock and Other Ownership Interests - Allogene Therapeutics
 
Nizar Tannir
Stock and Other Ownership Interests - Amgen; BioCryst; Johnson & Johnson/Janssen; Spdr S&P Pharmaceuticals ETF; Surface Oncology; Vanguard Health Care
Honoraria - AstraZeneca/Merck; Bristol-Myers Squibb; Eisai; Exelixis; Intellisphere; Merck Sharp & Dohme; Nektar; Oncorena
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Merck Sharp & Dohme; Nektar; Oncorena
Research Funding - Bristol Myers Squibb (Inst); Calithera Biosciences (Inst); Exelixis (Inst); Nektar (Inst); Novartis (Inst)
 
Ritesh Kotecha
Consulting or Advisory Role - Eisai; Eisai; Guidepoint Inc; Guidepoint Inc
Research Funding - Allogene Therapeutics (Inst); ArsenalBio (Inst); Exelixis (Inst); Novartis (Inst); Pfizer (Inst); Takeda (Inst); Xencor (Inst)